Suppression Tumorigenicity 2 (ST2) Turbidimetric Immunoassay Compared to Enzyme-Linked Immunosorbent Assay in Predicting Survival in Heart Failure Patients with Reduced Ejection Fraction

BACKGROUND: Suppressor of tumorigenicity 2 (ST2) is a powerful marker of prognosis and treatment response in heart failure (HF), however, it is an enzyme-linked immunosorbent assay (ELISA) which may be cumbersome and costly. A turbidimetric immunoassay (TIA) that can run on common chemistry analyzer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Chim Acta
Main Authors: Aurora, Lindsey, Peterson, Edward, Gui, Hongsheng, Zeld, Nicole, McCord, James, Pinto, Yigal, Cook, Bernard, Sabbah, Hani N., Williams, L. Keoki, Snider, James, Lanfear, David E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7572613/
https://ncbi.nlm.nih.gov/pubmed/32926842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cca.2020.08.039
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados